241 related articles for article (PubMed ID: 23299501)
1. Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment.
Wang N; Chai W; Zhao L; Tao L; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E538-45. PubMed ID: 23299501
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo.
Chai W; Wang W; Dong Z; Cao W; Liu Z
Diabetes; 2011 Nov; 60(11):2939-46. PubMed ID: 21896931
[TBL] [Abstract][Full Text] [Related]
3. Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery.
Zhao L; Chai W; Fu Z; Dong Z; Aylor KW; Barrett EJ; Cao W; Liu Z
Circ Res; 2013 Apr; 112(9):1263-71. PubMed ID: 23459195
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.
Vincent MA; Barrett EJ; Lindner JR; Clark MG; Rattigan S
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E123-9. PubMed ID: 12791603
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.
Fu Z; Zhao L; Aylor KW; Carey RM; Barrett EJ; Liu Z
Hypertension; 2014 Jun; 63(6):1219-27. PubMed ID: 24711523
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism.
Chai W; Dong Z; Wang N; Wang W; Tao L; Cao W; Liu Z
Diabetes; 2012 Apr; 61(4):888-96. PubMed ID: 22357961
[TBL] [Abstract][Full Text] [Related]
7. Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo.
Bradley EA; Richards SM; Keske MA; Rattigan S
Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E745-50. PubMed ID: 23900417
[TBL] [Abstract][Full Text] [Related]
8. Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle.
Premilovac D; Attrill E; Rattigan S; Richards SM; Kim J; Keske MA
Cardiovasc Res; 2019 Mar; 115(3):590-601. PubMed ID: 30192915
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFα.
Wang N; Ko SH; Chai W; Li G; Barrett EJ; Tao L; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E195-201. PubMed ID: 20978231
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use.
Chai W; Wang W; Liu J; Barrett EJ; Carey RM; Cao W; Liu Z
Hypertension; 2010 Feb; 55(2):523-30. PubMed ID: 19996061
[TBL] [Abstract][Full Text] [Related]
11. Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses.
Zhao L; Fu Z; Wu J; Aylor KW; Barrett EJ; Cao W; Liu Z
J Physiol; 2015 Sep; 593(17):4067-79. PubMed ID: 26108677
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans.
Liu J; Jahn LA; Fowler DE; Barrett EJ; Cao W; Liu Z
J Clin Endocrinol Metab; 2011 Feb; 96(2):438-46. PubMed ID: 21047922
[TBL] [Abstract][Full Text] [Related]
13. Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.
Chai W; Liu J; Jahn LA; Fowler DE; Barrett EJ; Liu Z
Diabetes Care; 2011 Jul; 34(7):1634-8. PubMed ID: 21617098
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance.
Chai W; Zhang X; Barrett EJ; Liu Z
Diabetes; 2014 Aug; 63(8):2788-99. PubMed ID: 24658303
[TBL] [Abstract][Full Text] [Related]
15. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo.
Vincent MA; Clerk LH; Lindner JR; Klibanov AL; Clark MG; Rattigan S; Barrett EJ
Diabetes; 2004 Jun; 53(6):1418-23. PubMed ID: 15161743
[TBL] [Abstract][Full Text] [Related]
16. Ranolazine recruits muscle microvasculature and enhances insulin action in rats.
Fu Z; Zhao L; Chai W; Dong Z; Cao W; Liu Z
J Physiol; 2013 Oct; 591(20):5235-49. PubMed ID: 23798495
[TBL] [Abstract][Full Text] [Related]
17. Muscle contraction, but not insulin, increases microvascular blood volume in the presence of free fatty acid-induced insulin resistance.
Inyard AC; Chong DG; Klibanov AL; Barrett EJ
Diabetes; 2009 Nov; 58(11):2457-63. PubMed ID: 19675134
[TBL] [Abstract][Full Text] [Related]
18. Fast relaxation and desensitization of angiotensin II contraction in the pulmonary artery via AT1R and Akt-mediated phosphorylation of muscular eNOS.
Kim HJ; Jang JH; Zhang YH; Yoo HY; Kim SJ
Pflugers Arch; 2019 Oct; 471(10):1317-1330. PubMed ID: 31468138
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
20. Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.
Lteif AA; Chisholm RL; Gilbert K; Considine RV; Mather KJ
Diabetes Obes Metab; 2012 Mar; 14(3):254-61. PubMed ID: 22051059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
